The company said the year-on-year improvement was primarily driven by the acquisition of Hindusthan Specialty Chemicals. Previous Post CAMS shares in focus post Q2 results, dividend announcement Next Post Explained — What led to the nearly 10% fall in Cohance Lifesciences shares on Wednesday Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
